Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Februar 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight

New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight The growing demand for immune checkpoint inhibitors is...
07. April 2022 11:00 ET | Quelle: Visiongain Ltd

Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Research Inc

Visiongain has published a new report: Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031: Forecasts by Category (PD1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Cytokines Targets,...
13. Dezember 2018 09:26 ET | Quelle: Visiongain Ltd

Visiongain launches a new pharma report: ‘Checkpoint Inhibitors for Treating Cancer Market Report 2018-2028: Analysing Prospects for PD-1 Inhibitors, CLTA-4 Inhibitors and Pipeline Drugs’

LONDON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint inhibitors are significant because they utilise the greatest tool that the body has to fight cancer - its own immune defence system. Checkpoint...